GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HPGC Renmintongtai Pharmaceutical Corp (SHSE:600829) » Definitions » Accumulated Depreciation

HPGC Renmintongtai Pharmaceutical (SHSE:600829) Accumulated Depreciation : ¥0 Mil (As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is HPGC Renmintongtai Pharmaceutical Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

HPGC Renmintongtai Pharmaceutical's quarterly accumulated depreciation increased from Sep. 2023 (¥0 Mil) to Dec. 2023 (¥-313 Mil) but then stayed the same from Dec. 2023 (¥-313 Mil) to Mar. 2024 (¥0 Mil).

HPGC Renmintongtai Pharmaceutical's annual accumulated depreciation increased from Dec. 2021 (¥-294 Mil) to Dec. 2022 (¥-305 Mil) and increased from Dec. 2022 (¥-305 Mil) to Dec. 2023 (¥-313 Mil).

HPGC Renmintongtai Pharmaceutical Accumulated Depreciation Historical Data

The historical data trend for HPGC Renmintongtai Pharmaceutical's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HPGC Renmintongtai Pharmaceutical Accumulated Depreciation Chart

HPGC Renmintongtai Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only Premium Member Only -277.22 -278.31 -293.87 -305.21 -313.02

HPGC Renmintongtai Pharmaceutical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -311.93 - -313.02 -

HPGC Renmintongtai Pharmaceutical Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

HPGC Renmintongtai Pharmaceutical Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of HPGC Renmintongtai Pharmaceutical's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

HPGC Renmintongtai Pharmaceutical (SHSE:600829) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HPGC Renmintongtai Pharmaceutical Corp (SHSE:600829) » Definitions » Accumulated Depreciation
Comparable Companies
SHSE:603520 SZSE:002644 SZSE:002688 SZSE:002940 SZSE:002923 SHSE:603669 SHSE:688799 SZSE:300485 SHSE:603676 SZSE:002900 XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
No. 76 Hengshan Road, Nangang District, Heilongjiang Province, Harbin, CHN, 150076
Website
http://www.sanjing.com.cn
HPGC Renmintongtai Pharmaceutical Corp, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co Ltd is engaged in the production and sale of pharmaceuticals products in China.
Executives
Yue Xian Zhi senior management
Zhang Li Jun Director

HPGC Renmintongtai Pharmaceutical (SHSE:600829) Headlines

No Headlines